BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28583788)

  • 1. Thyroid hormone receptor alpha (TRa) tissue expression in ductal invasive breast cancer: A study combining quantitative immunohistochemistry with digital slide image analysis.
    Charalampoudis P; Agrogiannis G; Kontzoglou K; Kouraklis G; Sotiropoulos GC
    Eur J Surg Oncol; 2017 Aug; 43(8):1428-1432. PubMed ID: 28583788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NKD1 down-regulation is associated with poor prognosis in breast invasive ductal carcinoma.
    Lv ZD; Zhang L; Liu XP; Jin LY; Dong Q; Li FN; Wang HB; Kong B
    Int J Clin Exp Pathol; 2015; 8(4):4015-21. PubMed ID: 26097589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid hormone receptor (TR)alpha and TRbeta expression in breast cancer.
    Ditsch N; Toth B; Himsl I; Lenhard M; Ochsenkühn R; Friese K; Mayr D; Jeschke U
    Histol Histopathol; 2013 Feb; 28(2):227-37. PubMed ID: 23275305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of immunohistochemical ERα, ERβ and ERβcx expressions in normal and neoplastic breast tissues.
    Bozkurt KK; Kapucuoğlu N
    Pathol Res Pract; 2012 Mar; 208(3):133-9. PubMed ID: 22336175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry].
    Masiuk M
    Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Breast ductal carcinoma in situ with microinvasion: pathological review and clinical implications].
    Modesto A; Gandy C; Mery E; Filleron T; Massabeau C; Izar F; Charitansky H; Roché H; de Lafontan B
    Cancer Radiother; 2014 Mar; 18(2):107-10. PubMed ID: 24637020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between parameters from virtual touch tissue quantification (VTQ) imaging with clinicopathologic prognostic factors in women with invasive ductal breast cancer.
    Xie J; Wu R; Xu HX; Yao MH; Xu G
    Int J Clin Exp Pathol; 2014; 7(10):6644-52. PubMed ID: 25400743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast.
    Tsutsui S; Inoue H; Yasuda K; Suzuki K; Higashi H; Era S; Mori M
    Oncology; 2005; 68(4-6):398-404. PubMed ID: 16020969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Breast Tumor Strain Ratio Is a Predictive Parameter for Axillary Lymph Node Metastasis in Patients With Invasive Breast Cancer.
    Kim JY; Shin JK; Lee SH
    AJR Am J Roentgenol; 2015 Dec; 205(6):W630-8. PubMed ID: 26587952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 expression in ductal carcinoma of the breast and its correlation with other prognostic parameters.
    Ravikumar G; Ananthamurthy A
    J Cancer Res Ther; 2014; 10(3):671-5. PubMed ID: 25313758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of beclin-1 in the microenvironment of invasive ductal carcinoma of the breast: correlation with prognosis and the cancer-stromal interaction.
    Morikawa A; Takeuchi T; Kito Y; Saigo C; Sakuratani T; Futamura M; Yoshida K
    PLoS One; 2015; 10(5):e0125762. PubMed ID: 25955408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDIA3 and PDIA6 gene expression as an aggressiveness marker in primary ductal breast cancer.
    Ramos FS; Serino LT; Carvalho CM; Lima RS; Urban CA; Cavalli IJ; Ribeiro EM
    Genet Mol Res; 2015 Jun; 14(2):6960-7. PubMed ID: 26125904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of survivin and its clinicopathological correlations in invasive ductal carcinoma of the breast.
    Al-Joudi FS; Iskandar ZA; Hasnan J; Rusli J; Kamal Y; Imran AK; Ahmed M; Zakaria J
    Singapore Med J; 2007 Jul; 48(7):607-14. PubMed ID: 17609820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression patterns and correlations of claudin-6, methy-CpG binding protein 2, DNA methyltransferase 1, histone deacetylase 1, acetyl-histone H3 and acetyl-histone H4 and their clinicopathological significance in breast invasive ductal carcinomas.
    Xu X; Jin H; Liu Y; Liu L; Wu Q; Guo Y; Yu L; Liu Z; Zhang T; Zhang X; Dong X; Quan C
    Diagn Pathol; 2012 Mar; 7():33. PubMed ID: 22455563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical study of KiSS1 and KiSS1R expression in human primary breast cancer: Association with breast cancer receptor status, proliferation markers and clinicopathological features.
    Jarzabek K; Koda M; Kozlowski L; Milewski R; Wolczynski S
    Histol Histopathol; 2015 Jun; 30(6):715-23. PubMed ID: 25535062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer.
    Kapucuoğlu N; Bozkurt KK; Başpınar Ş; Koçer M; Eroğlu HE; Akdeniz R; Akçil M
    Pathol Res Pract; 2015 Oct; 211(10):740-7. PubMed ID: 26298632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
    Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
    Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.